Search Results

Reaching TAVR's Full Potential by Optimizing Postprocedure Care

Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc

Ask the Experts: Should the CMS NCD Requirement for Surgical and Interventional Co-Operators for TAVR Procedures Be Dropped?

With John C. Alexander, MD; Atul Chawla, MD; David X. Zhao, MD; Nirat Beohar, MD, FACC, FSCAI; and Mohamed Abdel-Wahab, MD, FESC

New Insights From the STS/ACC TVT Registry

What these ongoing data tell us about TAVR and future areas of interest.

By Frederick L. Grover, MD, and David R. Holmes Jr, MD

Transcatheter Valve Therapies

By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI

Insight on the role of oral anticoagulation as default antithrombotic strategy after transcatheter aortic valve implantation.

By Antonio Greco, MD, and Davide Capodanno, MD, PhD

Percutaneous Mitral Valve Repair

An overview of the current devices and techniques.

By Raymond Leung, MDCM, and Ted Feldman, MD